Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

Inclusion Criteria: * Willingness to participate * 18 years or older, either gender, any race * Must have Hepatitic C Virus Low Viral Load \[LCV LVL\] (positive, but \<600,000 IU/mL on the assay used by the individual study site. Only Hepatitis C Virus-Ribonucleic acid/quantitative polymerase chain reaction \[HCV-RNA/qPCR\] assays with results in IU/ml are acceptable) AND been diagnosed with Genotype 1 * Subject considered suitable for treatment per local label * Investigator considers suitable and subject consents to be treated Exclusion Criteria: * Does not show negative polymerase chain reaction \[PCR\] at week 4 * Pregnant women or those who plan to become pregnant or sexual partners of women who plan to become pregnant * Subject does not qualify based on contra-indication, special warning, special population, and/or pregnancy \& lactation section of the Summary of Product Characteristics \[SmPC\]